Company profile
Cue Biopharma
- Industry
- Biotechnology Research
- Employees
- 40
- Headquarters
- Boston, Massachusetts
- Founded
- 2014
- LinkedIn followers
- 5,458
- Office locations
- 1
Cue Biopharma company summary
Cue Biopharma is a company in the Biotechnology Research industry, headquartered in Boston, Massachusetts, founded in 2014. On LinkedIn the company has around 40 employees and 5,458 followers.
What technology does Cue Biopharma use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Cue Biopharma
Cue Biopharma, a clinical-stage biopharmaceutical company is developing a novel class of therapeutic biologics to selectively engage and modulate disease-relevant T cells for the treatment of autoimmune disease. Cue Biopharma’s proprietary platform, Immuno-STAT® (Selective Targeting and Alteration of T Cells) and biologics are designed to harness the curative potential of the body’s innate immune system through the selective modulation of disease-relevant T cells without the adverse effects of broad systemic immune activation.
Where is Cue Biopharma located?
Cue Biopharma lists 1 location.
Compare companies similar to Cue Biopharma
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Cue Biopharma cuebiopharma.com | Biotechnology Research | 40 | 2014 | Boston, Massachusetts |
Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Cue Biopharma
What does Cue Biopharma do?
Cue Biopharma, a clinical-stage biopharmaceutical company is developing a novel class of therapeutic biologics to selectively engage and modulate disease-relevant T cells for the treatment of autoimmune disease. Cue Biopharma’s proprietary platform, Immuno-STAT® (Selective Targeting and Alteration of T Cells) and biologics are designed to harness the curative potential of the body’s innate immune system through the selective modulation of disease-relevant T cells without the adverse effects of broad systemic immune activation.
How many employees does Cue Biopharma have?
Cue Biopharma has around 40 employees on LinkedIn.
Where is Cue Biopharma headquartered?
Cue Biopharma is headquartered in Boston, Massachusetts.
When was Cue Biopharma founded?
Cue Biopharma was founded in 2014.
Build a lead list from companies like Cue Biopharma
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.